The correlations between serum HIF-1α levels and the number of migraine headache days/month, migraine duration, HADS-A and HADS-D scores, suggest that elevated serum HIF-1α levels are associated with increased migraine headache frequency, migraine chronification, and higher anxiety and depression scores. Here, HIF1A is linked to depressive symptom measurement.